Medical News

RSS

Study finds SARS-CoV-2 infection caused significant changes in the levels of stress associated small RNAs

In this study, researchers described the effect of significant changes of small RNAs in the post-transcriptional regulatory network.

13 Jan 2022

Psychological distress in AYA cancer survivors linked to health care use and additional medical expenses

New research indicates that psychological distress from cancer and its treatment can cause many adolescent and young adult (AYA) cancer survivors to seek additional care and burden them with considerable medical expenses.

13 Jan 2022

Young children’s mobility, motor skills linked with good vision and eye health

Toddler and young children’s mobility and motor skills – and preschool development – are closely aligned with good vision and eye health.

13 Jan 2022

Defective gene in blood cancers could be treated with already available drugs

A defective gene, normally found in blood cancers, could be treated with drugs already available for cancers with similar gene defects, scientists at Queen’s University Belfast and the University of Birmingham have revealed.

13 Jan 2022

Novel biomarker can be used to identify disease progression in ALS

An international collaboration led by Flinders University has identified a potential biomarker for amyotrophic lateral sclerosis, also known as Motor Neuron Disease, providing a way to test the effectiveness of future clinical trials.

13 Jan 2022

Exploring healthcare workers' opinions on mandatory COVID-19 vaccination in the UK

In a new study, researchers determined healthcare workers' views on mandatory severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccination in the United Kingdom.

13 Jan 2022

SARS-CoV-2-specific immune responses elicited by inactivated COVID-19 vaccines

In this study, researchers identified and recruited volunteers who received inactivated COVID-19 vaccines in real-world settings.

13 Jan 2022

Exploring factors favoring transmission of SARS-CoV-2 Delta sublineage AY.4.2 over the Delta variant

In the present study, researchers isolated an infectious AY.4.2 strain of COVID-19 from the nasopharyngeal swab of a symptomatic individual from the Paris region. Then, they introduced the AY.4.2 signature mutations - T95I, Y145H, and A222V - in an expression plasmid coding the Delta protein to study the function of the AY.4.2 S protein.

13 Jan 2022

Forecasting seasonal SARS-CoV-2 mutations

In a study published in Science Translational Medicine, researchers have been trying to create a technique to predict which of these mutations will spread.

13 Jan 2022

COVID-19 infection sera analysis against varying antigens of SARS-CoV-2 variants

In a new study, researchers assessed the sera from COVID-19 infected and vaccinated individuals against the receptor-binding domain in the spike protein of the SARS-CoV-2 wildtype virus and its variants.

13 Jan 2022

Low incidence strategy for control of COVID-19

In a study published in The Lancet Regional Health – Europe, researchers from the Institute for Advanced Studies in Vienna argued for the benefits of a low incidence strategy to control the disease.

13 Jan 2022

Long-excluded uterine cancer patients are step closer to 9/11 benefits

Tammy Kaminski can still recall the taste of benzene, a carcinogenic byproduct of burning jet fuel. For nine months after the 9/11 attacks, she volunteered for eight hours every Saturday at St. Paul's Chapel, just around the corner from ground zero in New York City.

13 Jan 2022

Study finds reductions in hospital admissions for childhood infections during first year of pandemic

During the first year or so of the covid-19 pandemic, there were dramatic reductions in hospital admissions for common and severe childhood infections in England, most likely due to social distancing measures, school and workplace closures, and travel restrictions, finds a study published by The BMJ today.

13 Jan 2022

Nanovaccines and their immunomodulatory effect against human viruses

A review ]presented the primary progress of nanovaccines against the main viral illnesses.

13 Jan 2022

The unique T cell response elicited by SARS-CoV-2 during a primary immune response by infection and vaccination

The distinctive characteristics of the T cell response generated by SARS-CoV-2 infection and vaccination and the relationship to CCCoVs and VOC was explored in a review published in Frontiers in Medicine.

13 Jan 2022

Using lab-grown stomachs to shed light on the symptoms of COVID-19

Could lab-grown 'mini-stomachs' be used to look at COVID-19 symptoms in children? In this interview, we speak to Paolo De Coppi to find out more.

13 Jan 2022

Specific behavioral markers can indicate developmental problems in preterm infants

There are a number of risks associated with preterm infants born before 32 weeks. One of these is an increased chance of behavioral and attention problems. Previous studies suggest there might be early indicators of problems that develop in childhood, but results lacked consistency.

13 Jan 2022

$Common osteoporosis medications protect against hip fracture during a 2-year drug holiday$

Common osteoporosis medications protect against hip fracture during a 2-year drug holiday

New research findings may help physicians and older adults with osteoporosis better manage their hip fracture risk while taking a break from their medication. The first-of-its-kind study, published in the Annals of Internal Medicine, found that the oral bisphosphonates risedronate and alendronate equally protect against hip fracture during a 2-year drug holiday.

13 Jan 2022

Moffitt experts provide insight on the role of B cell immunity in endometrial cancer

Endometrial cancer is the most common cancer of the female reproductive system. Patients who have active immune responses against cancer cells tend to have better outcomes, but much of what is known focuses on only one type of immune cell called T cells.

13 Jan 2022

Cannabinoids may prevent infection with SARS-CoV-2, including variants

A new study published in the Journal of Natural Products of the American Chemical Society and American Society of Pharmacognosy has shown that isolated cannabinoids or those in hemp extracts have the potential to prevent and treat the infection with the severe acute respiratory syndrome coronavirus 2 (SARS‑CoV‑2) – primarily by blocking viral cell entry.

13 Jan 2022

Medical News

Study finds SARS-CoV-2 infection caused significant changes in the levels of stress associated small RNAs

Psychological distress in AYA cancer survivors linked to health care use and additional medical expenses

Young children’s mobility, motor skills linked with good vision and eye health

Defective gene in blood cancers could be treated with already available drugs

Novel biomarker can be used to identify disease progression in ALS

Exploring healthcare workers' opinions on mandatory COVID-19 vaccination in the UK

SARS-CoV-2-specific immune responses elicited by inactivated COVID-19 vaccines

Exploring factors favoring transmission of SARS-CoV-2 Delta sublineage AY.4.2 over the Delta variant

Forecasting seasonal SARS-CoV-2 mutations

COVID-19 infection sera analysis against varying antigens of SARS-CoV-2 variants

Low incidence strategy for control of COVID-19

Long-excluded uterine cancer patients are step closer to 9/11 benefits

Study finds reductions in hospital admissions for childhood infections during first year of pandemic

Nanovaccines and their immunomodulatory effect against human viruses

The unique T cell response elicited by SARS-CoV-2 during a primary immune response by infection and vaccination

Using lab-grown stomachs to shed light on the symptoms of COVID-19

Specific behavioral markers can indicate developmental problems in preterm infants

Common osteoporosis medications protect against hip fracture during a 2-year drug holiday

Moffitt experts provide insight on the role of B cell immunity in endometrial cancer

Cannabinoids may prevent infection with SARS-CoV-2, including variants

The impact of vibration on microscopy

How Omics Technologies Are Transforming Biological Research and Drug Discovery

How microplastics and bacteria interact to drive antibiotic resistance

Latest News